Company
Biofire Diagnostics
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
34
510(k), De Novo and PMA
Device trials
2
As lead sponsor, any status
Adverse event reports
170
Received Nov 1, 2025 to Nov 19, 2026
Recall records
47
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Biofire Diagnostics, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Biofire Diagnostics.
Latest FDA decisions
The 8 newest of 34 since 2015.
K262172 · Decided Nov 6, 2026 · 133 days after receipt
Device type: Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System (PCH) · Laboratory Medicine & Pathology
K262136 · Decided Oct 21, 2026 · 118 days after receipt
Device type: Vaginitis And Bacterial Vaginosis Nucleic Acid Detection System (PQA) · Laboratory Medicine & Pathology
K263054 · Decided Sep 22, 2026 · 21 days after receipt
Device type: Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents (QOF) · Laboratory Medicine & Pathology
31 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT02248285 · 1,545 participants · Start Apr 2015 · Primary completion Aug 2016
Device: FilmArray™ Gastrointestinal (GI) Panel · For: Infectious Gastroenteritis
Sites: Los Angeles, California; Kansas City, Missouri; Columbus, Ohio · 5 sites in all
NCT03029299 · 83 participants · Start Apr 4, 2017 · Primary completion Sep 15, 2017
Device: FilmArray RP EZ · For: Respiratory Tract Infections
Sites: Los Angeles, California
Reports received
170
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
70
41% of reports
Injury reports
96
56% of reports
Death reports
4
2.4% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 96 | 6 | 0 | 0 |
| Jan 24 | 242 | 0 | 0 | 0 |
| Feb 24 | 25 | 0 | 0 | 0 |
| Mar 24 | 29 | 0 | 0 | 0 |
| Apr 24 | 21 | 0 | 0 | 0 |
| May 24 | 32 | 0 | 0 | 0 |
| Jun 24 | 14 | 0 | 0 | 0 |
| Jul 24 | 3 | 0 | 0 | 0 |
| Aug 24 | 11 | 2 | 1 | 0 |
| Sep 24 | 21 | 1 | 0 | 0 |
| Oct 24 | 8 | 1 | 0 | 0 |
| Nov 24 | 12 | 0 | 1 | 0 |
| Dec 24 | 9 | 1 | 0 | 0 |
| Jan 25 | 7 | 0 | 0 | 0 |
| Feb 25 | 4 | 5 | 0 | 0 |
| Mar 25 | 3 | 2 | 3 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 32 | 1 | 0 | 0 |
| Jun 25 | 8 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 4 | 0 | 0 | 0 |
| Sep 25 | 7 | 3 | 2 | 0 |
| Oct 25 | 1 | 0 | 0 | 0 |
| Nov 25 | 1 | 2 | 1 | 0 |
| Dec 25 | 1 | 0 | 0 | 0 |
| Jan 26 | 0 | 1 | 1 | 0 |
| Feb 26 | 0 | 1 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 4 | 1 | 1 | 0 |
| May 26 | 5 | 0 | 1 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 3 | 4 | 0 | 0 |
| Aug 26 | 19 | 14 | 0 | 0 |
| Sep 26 | 5 | 27 | 0 | 0 |
| Oct 26 | 32 | 46 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
6 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0148-2027 · Started Aug 12, 2026 · Posted by FDA Oct 13, 2026
Reason given: Due to potential contaiminated of spefic lots of pneumonia and joint infection panels that could result in false positive results
Cause as FDA categorized it: Under Investigation by firm · Device type: Respiratory Panel (QDP)
Z-0149-2027 · Started Aug 12, 2026 · Posted by FDA Oct 13, 2026
Reason given: Due to potential contaiminated of spefic lots of pneumonia and joint infection panels that could result in false positive results
Cause as FDA categorized it: Under Investigation by firm · Device type: Mers-Cov And Common Respiratory Pathogens Semi-Quantitative And Quantitative Multiplex Nucleic Acid Detection System (QDS)
Z-0150-2027 · Started Aug 12, 2026 · Posted by FDA Oct 13, 2026
Reason given: Due to potential contaiminated of spefic lots of pneumonia and joint infection panels that could result in false positive results
Cause as FDA categorized it: Under Investigation by firm · Device type: Orthopedic Infection Microbial Multiplex Nucleic Acid Detection System (QSN)
44 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.